Optum Rx, the pharmacy benefit manager owned by UnitedHealth Group, placed Journavx on some of its commercial formularies in ...

Vertex's Journavx, a new non-opioid pain drug, lands Tier 3 on Optum Rx formularies. Vertex reports $2.91 billion Q4 sales.

The “Big Three” PBMs are kicking their suit up to the 8th Circuit and, in the meantime, are once again asking a Missouri district judge to halt the FTC’s administrative case against them.

Aetna Inc. and OptumHealth Care Solutions Inc. signed a settlement worth $8.35 million that’s aimed at resolving a class ...

The Boston-based company's new medication, called Journavx, is being placed on a tier that means it might be costlier than ...

A healthcare company targeted by U.S. Rep. Pat Ryan as part of a service probe said that its facilities have undergone much ...

We recently compiled a list of the 10 Best Low Risk Stocks To Buy in 2025. In this article, we are going to take a look at where UnitedHealth Group Incorporated (NYSE:UNH) stands against the other ...

U.S. Rep. Pat Ryan has launched a community inquiry effort into care quality and accessibility matters at Optum-owned medical ...

The promise of integrated care is well understood: better patient outcomes, more efficient use of NHS resources and a more ...

UnitedHealth Group faced two new investigations from federal lawmakers. The first was a senator’s probe into its Medicare ...